Neue Medikamente bei Migräneattacken: Marketing und Realität
Crossref DOI link: https://doi.org/10.1007/s15005-024-3850-x
Published Online: 2024-02-21
Published Print: 2024-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Diener, Hans-Christoph
Text and Data Mining valid from 2024-02-01
Version of Record valid from 2024-02-01
Article History
First Online: 21 February 2024
Free to read: This content has been made available to all.